Aakha Biologics
PrivateLast Round
Debt
Jul 23, 2024
Total Funding Raised
$3.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aakha Biologics operates in Healthcare & Life Sciences and is based in Frisco, Texas. Its latest recorded funding round was a Seed round in July 2024.
Aakha Biologics is a biotechnology company that develops next-generation multi-specific antibody immunotherapies for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aakha Biologics Comparables
Compare Aakha Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ypsilon Therapeutics | 83% | |
| Cantai Therapeutics | 82% | |
| Novelogics Biotechnology | 78% |
For institutional investors. Book with your work email.
Aakha Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 23, 2024 | ||||
| Seed | Jul 17, 2024 | ||||
| Grant | May 22, 2024 | ||||
| Accelerator | May 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aakha Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Opus8 | Seed |
| 82VS | Accelerator |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Grew 60% QoQ from 5 to 8 employees.
- May 24, 2026
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
Aakha Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aakha Biologics's valuation, stock price, and market status.
Is Aakha Biologics a public or private company?
Aakha Biologics is a private company.
What is the current stock price of Aakha Biologics?
Aakha Biologics is a private company, so its shares have no public market price. Caplight tracks Aakha Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aakha Biologics worth (valuation)?
Valuation information for Aakha Biologics is not publicly available.
Can I buy Aakha Biologics stock?
Aakha Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aakha Biologics's last funding round?
Aakha Biologics's most recent funding round was Debt on July 23, 2024.
Who are the main investors in Aakha Biologics?
Key investors in Aakha Biologics include National Cancer Institute, Opus8, 82VS, Cancer Prevention and Research Institute of Texas.
Will Aakha Biologics IPO soon?
No public IPO plans have been announced for Aakha Biologics.
How can I track Aakha Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Aakha Biologics's shares on secondary markets.